Larvol Delta - Early-and-Sustained-Improvements-in-Fatigue-and-Physical-Function-with-Secukinumab-in-Patients-with-Psoriatic-Arthritis-A-Pooled-Analysis-of-FUTURE-Studies

Cosentyx (secukinumab) - Novartis

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898454&mode=presInfo

Philip J. Mease, MD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next